Written by Ι Stock Market Media — May 30, 2018
Today Stock Market Media Group is releasing its latest Interview in our series of CEO Interviews. Today we welcome PharmaCyte Biotech (OTCQB: PMCB) a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, and the company’s Chief Executive Officer, Kenneth L. Waggoner, and its Chief Scientific Officer, Prof. Walter H. Günzburg.
Read More →MAY